tirzepatide stopping period TrimRX Endoscopic Procedure Shows Promise for

doi: 10.1503/cmaj.240768

In recent years, Ozempic has been in the headlines for its off-label use for weight loss

NEJM, 2021. U.S

At the 10mg dose, tirzepatide achieves plasma concentrations that exceed the activation threshold for both receptors by substantial margins, roughly 10,000-fold above the EC50 for the GIP receptor and 250-fold above the EC50 for the GLP-1 receptor

The Phase 2 trial is the only controlled human efficacy study

Comprehensive Support: Nutrition and Lifestyle Integration in GLP-1 Programs Achieving effective weight loss with these medications involves more than just a pharmacological approach